Alnylam CEO Yvonne Greenstreet got an $18M equity award tied to performance through 2029 after the drugmaker's first ...
Cognito Therapeutics just closed a $105 million funding round to prepare for a crucial data readout this summer and an FDA submission.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results